通过AT1R依赖机制向基因B1R减轻高血压
Drew Theobald1, Riley N Bessetti2, Yumei Feng Earley3
1Department of Pharmacology and Toxicology, Brody School of Medicine at East Carolina University, Greenville, NC. (D.T., S.S.).
Circulation research
|August 20, 2025
概括
通过增加交感活性和神经炎症,素B1受体 (B1R) 的激活有助于Ang II诱导的高血压. 阻断B1R是治疗高血压的一个潜在策略.
科学领域:
- 心血管研究
- 神经科学
- 药理学
背景情况:
- 神经性高血压涉及过度的同情活动和素B1受体 (B1R) 激活.
- 之前的研究将B1R与高血压的炎症途径以及神经炎症和氧化应激之间的相互作用联系起来.
- 在Ang II诱导的高血压中,Ang II型I受体 (AT1R) 与B1R之间的相互作用尚未研究.
研究的目的:
- 研究B1R在Ang II引起的高血压中的作用.
- 确定B1R激活是否有助于交感兴奋,自主功能障碍,氧化应激和炎症.
- 探索B1R和AT1R之间的潜在相互作用.
主要方法:
- 使用Ang II诱导高血压的小鼠模型.
- 比较野生型和B1R敲除小鼠注入Ang II或盐水.
- 评估功能和分子变化,包括同情激发,自主功能和B1R/AT1R相互作用.
主要成果:
- 在野生型小鼠中,Ang II增加了B1R的表达,导致血压升高,同情刺激和自主功能障碍.
- 在B1R基因缺乏的小鼠中,这些影响显著减弱.
- 发现B1R与AT1R直接相互作用,介导神经炎症和神经元活动的改变.
结论:
- 这项研究提供了B1R在Ang II引起的高血压中的作用的第一个证据.
- B1R与AT1R相互作用,并通过神经炎症和交感过度活动导致高血压.
- 在高血压治疗中,B1R是一个有前途的治疗点.
相关概念视频
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
910
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
910
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
869
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
869
01:17Antihypertensive Drugs: Action of β1 Blockers
608
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
608
01:25Antihypertensive Drugs: Direct Renin Inhibitors
817
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
817
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
01:29Hypertension II: Pathophysiology
73
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
73